Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study

Bibliographic Details
Title: Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study
Authors: Tourneau, Christophe Le, Calugaru, Valentin, Moreno, Victor, Calvo, Emiliano, Liem, Xavier, Salas, Sébastien, Doger, Bernard, Jouffroy, Thomas, Mirabel, Xavier, Rodriguez, Jose, Chilles, Anne, Bernois, Katell, Fakhry, Nicolas, Kam, Stéphanie Wong Hee, Hoffmann, Caroline
Source: In Oral Oncology July 2021 118 Supplement:11-11
Database: ScienceDirect
More Details
ISSN:13688375
DOI:10.1016/S1368-8375(21)00278-5
Published in:Oral Oncology
Language:English